Search research articles
Contact Us
Filters
Showing results (51-60 of 227) with videos related to
Page
of 23
Sort By:
Blood Advances
|
October 19, 2021
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant
Mary Nauffal, Haesook T Kim, Paul G Richardson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 28, 2014
BK virus disease after allogeneic stem cell transplantation: a cohort analysis
Nienke M G Rorije, Margaret M Shea, Gowri Satyanarayana, et al.
Leukemia & Lymphoma
|
March 30, 2026
Allogeneic transplant outcomes in T-cell prolymphocytic leukemia: a single-center retrospective study
Mwanasha Merrill, Haesook T Kim, Amar H Kelkar, et al.
Haematologica
|
March 26, 2017
Venous thromboembolism is associated with graft-<i>versus</i>-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation
Natasha Kekre, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 13, 2011
The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantation
Karim E Abou-Nassar, Haesook T Kim, Jeff Blossom, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 28, 2010
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome
John Koreth, Melinda Biernacki, Julie Aldridge, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 29, 2007
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation
Philippe Armand, Haesook T Kim, Daniel J DeAngelo, et al.
Blood
|
August 29, 2009
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
John Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Blood
|
May 6, 2003
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
Joseph H Antin, Haesook T Kim, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 4, 2011
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation
Vincent T Ho, Haesook T Kim, Julie Aldridge, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 227) with videos related to
Sort By:
Page
of 23
Blood Advances
|
October 19, 2021
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant
Mary Nauffal, Haesook T Kim, Paul G Richardson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 28, 2014
BK virus disease after allogeneic stem cell transplantation: a cohort analysis
Nienke M G Rorije, Margaret M Shea, Gowri Satyanarayana, et al.
Leukemia & Lymphoma
|
March 30, 2026
Allogeneic transplant outcomes in T-cell prolymphocytic leukemia: a single-center retrospective study
Mwanasha Merrill, Haesook T Kim, Amar H Kelkar, et al.
Haematologica
|
March 26, 2017
Venous thromboembolism is associated with graft-<i>versus</i>-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantation
Natasha Kekre, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 13, 2011
The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantation
Karim E Abou-Nassar, Haesook T Kim, Jeff Blossom, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 28, 2010
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome
John Koreth, Melinda Biernacki, Julie Aldridge, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 29, 2007
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation
Philippe Armand, Haesook T Kim, Daniel J DeAngelo, et al.
Blood
|
August 29, 2009
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donors
John Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Blood
|
May 6, 2003
Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation
Joseph H Antin, Haesook T Kim, Corey Cutler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 4, 2011
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation
Vincent T Ho, Haesook T Kim, Julie Aldridge, et al.
Page
of 23